Evidence map›Paper›PMID 34918741›Full record

ArticleDevelopment (Cambridge, England)2021

Intermediate progenitor cells provide a transition between hematopoietic progenitors and their differentiated descendants.

Carrie M Spratford, Lauren M Goins, Fangtao Chi, Juliet R Girard, Savannah N Macias, Vivien W Ho, Utpal Banerjee

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Niche-derived exosomes controlFrontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. TheeLife · 2025
    Article
  8. Article
  9. ThebioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Peeling Back the Layers of Lymph Gland Structure and Regulation.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carrie M SpratfordDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0003-3703-8611
Lauren M GoinsDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0001-8422-2038
Fangtao ChiDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0002-5730-2830
Juliet R GirardDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0001-8274-2136
Savannah N MaciasDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0002-0797-1470
Vivien W HoDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0002-2992-0252
Utpal BanerjeeDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA.ORCID 0000-0001-6247-0284
University of California, Los Angeles · US

Funding

TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
Genomic and Genetic Dissection of Hematopoietic Development in DrosophilaR01HL067395 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SIEKHAUS, DARIA E · 2001 to 2025
$9.0M
Vascular Biology Training GrantT32HL069766 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2002 to 2022
$7.4M
UPLIFT: UCLA Postdocs' Longitudinal Investment in Faculty TrainingK12GM106996 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAREY, MICHAEL F, VILLANUEVA, CLAUDIO J · 2016 to 2025
$7.1M
Metabolic and signaling control of tumorformation in drosophilaR01CA217608 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BANERJEE, UTPAL · 2017 to 2021
$1.8M
NCI NIH HHS R01 CA217608NCI NIH HHS T32 CA009056NHLBI NIH HHS R01 HL067395NHLBI NIH HHS T32 HL069766NIGMS NIH HHS K12 GM106996
6 · The paper itself

Abstract

Genetic and genomic analysis in Drosophila suggests that hematopoietic progenitors likely transition into terminal fates via intermediate progenitors (IPs) with some characteristics of either, but perhaps maintaining IP-specific markers. In the past, IPs have not been directly visualized and investigated owing to lack of appropriate genetic tools. Here, we report a Split GAL4 construct, CHIZ-GAL4, that identifies IPs as cells physically juxtaposed between true progenitors and differentiating hemocytes. IPs are a distinct cell type with a unique cell-cycle profile and they remain multipotent for all blood cell fates. In addition, through their dynamic control of the Notch ligand Serrate, IPs specify the fate of direct neighbors. The Ras pathway controls the number of IP cells and promotes their transition into differentiating cells. This study suggests that it would be useful to characterize such intermediate populations of cells in mammalian hematopoietic systems.

Indexed as

AnimalsBlood CellsCell DifferentiationCell LineageDrosophila melanogasterDrosophila ProteinsHematopoiesisHematopoietic Stem CellsHemocytesJagged-1 ProteinLectinsReceptors, InterleukinReceptors, NotchSignal TransductionStem CellsTranscription Factorsdome protein, DrosophilaDrosophila ProteinsGAL4 protein, DrosophilaHml protein, DrosophilaJagged-1 ProteinLectinsN protein, DrosophilaReceptors, InterleukinReceptors, NotchSer protein, DrosophilaTranscription FactorsBlood cell developmentCrystal cellsDrosophilaHematopoiesisIntermediate progenitorSplit GAL4

Identifiers

PMID34918741
PMCPMC8722385
OpenAlexW4226086563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.